skin GVHD and elevated liver function tests. Splenomegaly resolved by day 72 post-transplant. Acute GVHD responded to steroids. Repeat bone marrow aspiration 100 Chronic lymphocytic leukemia (CLL) is incurable with conventional therapy. Recent data report favorable days post-transplant revealed hypercellular marrow with trilineage hematopoiesis and myeloid predominance withresults with allogeneic transplant. We report a patient with CLL with persistent leukemia post-transplant who out CLL. Fluorescence in situ hybridization showed only donor cells. Nine months post-transplant, the patient is in obtained remission after discontinuing immune suppression.
A 43-year-old white male developed CLL in 1991. He GVL is well described after allotransplants for leukemia. [1] [2] [3] [4] [5] [6] [7] [8] progressed well until 1994 when he developed anemia at Also, higher relapse rates are reported in patients with which time he received six cycles of fludarabine with a lymphoma after autologous vs allogeneic transplants. good hematologic response. In 1995, he developed pure Tricot et al 8 reported remissions in transplant patients red cell aplasia and underwent treatment with cyclosporwith multiple myeloma after onset of acute GVHD from ine with no response and subsequently received four infusing donor lymphocytes. The GVL effect has been cycles of cyclophosphamide, doxorubicin, vincristine, employed to induce remission in patients relapsing after prednisone. However, his disease progressed and he was allogeneic transplantation. There are some reports of referred for an allogeneic blood cell transplant. Physical GVL in patients with CLL receiving allotransplants. 9,10 A examination revealed marked splenomegaly and axillary case similar to ours was reported by Rondon et al. 10 This lymphadenopathy. He received busulfan, 16 mg/kg, over patient had persistent lymphocytosis and lymphadenopa-4 days and cyclophosphamide, 60 mg/kg, for 2 days. thy post-transplant and achieved remission after receiving Blood cells from his HLA-identical sister were infused.
donor lymphocytes 87 days post-transplant. Mehta et al 9 GVHD prophylaxis was with tacrolimus. His post-transreported a patient with CLL with disease progression plant course was uneventful save for mucositis and fevers post-transplant who seemed to improve when immuntreated with broad spectrum antibiotics. Because of suppression was stopped. These cases suggest that GVL nephrotoxicity tacrolimus was stopped 25 days post-transmay control disease after transplant. plant and prednisone started. Thirty days post-transplant, the bone marrow aspirate showed 84% mature lymphocytes. 
